The cannabis plant produces literally hundreds of specialized molecules — cannabinoids, terpenes and flavonoids — that have been shown to deliver medicinal efficacy, lifestyle enhancement and even performance enhancement to human beings. For those afflicted with disease, medical cannabis has been found to offer a wide range of health benefits, from killing cancerous tumors to alleviating the pain of arthritis to reducing the number of seizures experienced by epileptic children.
Of these molecules, cannabinoids are the most cited and understood. The most infamous cannabinoid is tetrahydrocannabinol (THC), the molecule responsible for most of the psychoactive (psychotropic) and euphoric effects of cannabis, but that also has been found to successfully treat serious conditions, such as PTSD and cancer. Another notable cannabinoid is cannabidiol (CBD), a mostly non-psychoactive chemical that has been found to provide a wide range of medicinal benefits, including reductions in pain, anxiety and depression.
Endocannabinoids vs. Phytocannabinoids
First discovered in 1964 by Israeli researcher Raphael Mechoulam, phytocannabinoids from the cannabis plant interact with the human body by mimicking the molecular characteristics of chemicals produced internally. Called endocannabinoids, these internally manufactured molecules include anandamide and 2-AG.
Anandamide has been dubbed the “bliss molecule” because of its ability to decrease depression in humans. It plays a central role in the regulation and modulation of critical bodily functions such as mood, appetite, sleep, immune system efficiency and one’s ability to deal with stress and anxiety.
Synthetic cannabinoids emerged in the 1970s and are created in a laboratory. An example of it would be dronabinol (Δ9-THC synthetic), which is the active compound of Marinol, a medicine that comes in capsules and has been consumed in the US since 1985 to prevent nausea, vomiting, loss of appetite and loss of weight.
The Endocannabinoid System
All mammals, not merely humans, have evolved with a network of specialized cellular receptors throughout their bodies that are designed to bind with cannabinoids — both endocannabinoids such as anandamide and phytocannabinoids from cannabis — that is called the endocannabinoid system (ECS).
The fact that the ECS is present in all mammals is why companies and product lines dedicated to the health and wellness of household pets are beginning to emerge in legal cannabis markets. Dogs and cats suffering conditions such as arthritis, digestive issues, anxiety and pain can gain significant benefit from the cannabinoids in cannabis and hemp.
Anandamide production has been found to increase and temporarily spike in those who engage in endurance exercise on a regular basis. However, it metabolizes quickly, exhibiting a relatively short duration of effect. Anandamide hints at the chemical underpinnings of the significant health benefits of frequent and intense exercise—and the fact that the mere consumption of cannabinoids is not enough to establish and sustain optimal health of the ECS (a condition called homeostasis that means “balance”).
Both internally produced endocannabinoids and plant-based phytocannabinoids interface with the ECS via specialized cellular receptors that were discovered in the 1990s and called CB1 and CB2. CB1 receptors are found mostly in the brain and central nervous system, whereas CB2 receptors are located primarily in the organs and tissues of the immune system—including the thymus, skin, bone marrow, lymph nodes, spleen, bowel and the mucous membranes of the bladder, genitals, nose and throat.
Major Cannabinoids + Acidic Precursors
More than 113 cannabinoids have been isolated and identified within the cannabis plant — which is, technically, also a vegetable. Beyond the two major cannabis-derived molecules, THC and CBD, are a plethora of healthful cannabinoids that deliver a slew of desirable and beneficial efficacies for lifestyle consumers and patients alike. Among these are cannabichromene (CBC), cannabigerol (CBG), cannabinol (CBN) and tetrahydrocannabivarin (THCV).
Additional healthful cannabinoids include tetrahydrocannabinolic acid (THCA) and cannabidiolic acid (CBDA). These chemicals represent a class of cannabinoids dubbed acidic precursors. Think of acidic precursors as the larval caterpillar stage of what becomes the butterflies of THC and CBD.
While they provide significant benefits in terms of health and wellness, the exact effects of these molecules differ from their non-acidic versions. For example, while strains of cannabis that are potent in THC can exact a significant toll in terms of psychoactivity and euphoria, THCA delivers no such psychotropic effect. THCA does, however, offer anti-inflammatory and neuroprotective effects, making it helpful for conditions as wide-ranging as Alzheimer’s disease, arthritis, cancer, Crohn’s disease, fibromyalgia, multiple sclerosis and Parkinson’s.
The process by which the transmogrification from the chemical state of acidic precursor (THCA) to its child molecule (THC) occurs is significant (and can be accurately controlled by anyone). A process called decarboxylation, this conversion involves the application of heat (via flame, as in combustion, or from a hot surface or airstream, as in vaporization) to catalyze a chemical reaction in which the THCA molecule drops a carbon and two oxygen atoms (called a carboxyl ring, or COOH) to become THC — and gain its euphoric effects based on its newfound binding affinity with the CB1 receptors of the ECS.
Technically, maximum decarboxylation for a sample of cannabis flowers occurs most effectively when exposed to 220 degrees F (104 degrees C) for a period of 30 to 45 minutes. Decarboxylation is easy and convenient because it can be accomplished using a standard consumer oven.
Thus, one who eats the raw flowers of cannabis will gain significant medicinal benefits, but no euphoria. The simple application of a flame or hot air, however, leads to the nearly instantaneous transformation of these molecules into their chemical cousins, delivering beneficial — but sometimes very different — effects.
A 2017 research study entitled “Medicinal Cannabis: History, Pharmacology and Implications for the Acute Care Setting” that was published in the journal Pharmacy & Therapeutics found the cannabinoids of cannabis, such as THC and CBD, to be effective in the treatment of a wide range of diseases and conditions.
The study’s researchers stated, the “Beneficial cannabinoids exist, as evidenced by single-entity agents derived from cannabis containing the compounds THC and CBD.” The study concluded that “cannabis is relatively safe; therapy is self-titratable by the patient; and…therapy is relatively inexpensive compared with pharmaceutical agents.”
CBC is a powerful cannabinoid first isolated in 1964 by Israeli researcher Raphael Mechoulam. It is considered one of the “big six” cannabinoids that, according to Steep Hill Labs in Berkeley, California, is ten times more effective than CBD in treating anxiety and stress.
In a 2011 study conducted by cannabis research pioneer Ethan Russo entitled “Taming THC: Potential Cannabis Synergy and Phytocannabinoid-terpenoid Entourage Effects” and published in the British Journal of Pharmacology, Russo found that a CBC-extract displayed “pronounced antidepressant effect,” meaning it may be helpful for humans suffering from anxiety and depression.
Additional evidence of the medical benefits of cannabinoids derived from cannabis — this time for an ocular disease — was revealed in a 2008 study entitled “Possibilities of Applying Cannabinoids in the Treatment of Glaucoma” that was published in the journal Klinika Oczna. The study concluded that cannabinoids like CBG are “able to decrease intraocular pressure. These compounds are characterized by neuroprotection and vasodilatation properties that additionally substantiate their therapeutic utility in conservative treatment of glaucoma.”
Cannabis Classification System Announced for 2022 Emerald Cup Awards
One of the factors that make the Emerald Cup so important to California’s cannabis market is its continued strive for excellence and innovation. For the 2022 awards, the judging process is undergoing a transformation and with it comes a new cannabis classification system that will classify entries based on terpenes, flavour, and effects for anybody — from customers to budtenders, dispensaries, judges, and cultivators.
Cannabis Is More Than Just THC
The days of just searching out the highest THC totals are rapidly receding as research has now proven that terpenes are at the base of the entourage effect that customers desire are rapidly fading.
Terpenes, on the other hand, have mostly added to the consumer confusion already caused by overly broad Indica/Sativa/Hybrid terminology, whimsical strain names, irrelevant THC/CBD percentages, and other ambiguous factors that make selecting the best or correct strain a less-than-satisfying ordeal for even the most experienced cannabis connoisseurs.
The Emerald Cup competition will serve as a testbed for a new classification system for cannabis flowers. The event organisers and their testing partners at SC Labs decided to further break down the flower categories based on the chemometrics of each cultivar (better known as “chemovar” — the evolution of the term “dominant terpene”) evolving beyond last year’s flower category sorting by primary terpene content, in order to level the playing field and eliminate as much bias as possible in the blind/anonymous sampling done by Emerald Cup judges each year.
This paradigm-shifting insight sparked months of additional research and discussion, culminating in the Emerald Cup Cannabis Classification System based on PhytoFacts® powered by SC Labs.
The all-new classification system builds on last year’s approach of sorting flower entries by primary terpene content, leveraging a decade of Cannabis phytochemistry research between PhytoFacts®, developed by Napro Research in 2013, and a powerful database of over 250,000 terpene tests aggregated by SC Labs, dating back to their launch of terpene testing on Cannabis in 2013. The key class names were chosen to represent current terminology, are widely used in the business and are familiar to dispensaries and consumers. Each class is further explained using taste notes, effects, and popular strains or cultivars to promote understanding and acceptance.
The New Cannabis Classification System
The classes of the Emerald Cup Cannabis Classification Based on PhytoFacts® powered by SC Labs include:
“Jacks + Haze” Class
- Mostly ‘Sativa’-leaning varietals
- Tasting notes – Fruity, Pinesol, Haze
- Effects – Energizing, Cerebral, Artistically Inspiring
- Common Cultivars – Classic Trainwreck, Jack Herer, Durban Poison, Super Lemon Haze
- Terpenes Profile: Terpinolene, Caryophyllene, Myrcene
“Tropical + Floral” Class
- Mostly ‘Indica’-leaning varietals
- Tasting notes – Sweet, Floral, Tropical Fruit
- Effects – Calming, Soothing, Relaxing
- Common Cultivars – Super Skunk, Hawaiian, In the Pines, Dream Queen
- Terpenes Profile: Ocimene, Myrcene
“Sweets + Dreams” Class
- Mostly ‘Indica’-leaning varietals
- Tasting Notes – Fruity, Sweet, Woody, Hoppy, Herbaceous
- Effects – Relaxation, Couch Lock, Analgesic
- Common Cultivars – Blue Dream, Tangie, Forbidden fruit, Grandaddy Purple, Purple Urkel, Grape Ape, Cherry AK, God’s Gift, Purple Punch
- Terpenes Profile: Myrcene, Pinene, Caryophyllene
“OGs + Gas” Class
- True ‘Hybrid’ varietals
- Tasting Notes – Gas, Fuel, Sweet, Citrus, and Pepper
- Effect – Uplifting, Stimulating, Analgesic, Relaxation
- Common Cultivars – Classic OG Kush, ChemDawg, Sour Diesel, Gorilla Glue
- Terpenes Profile: Any combination or shifting codominance of Caryophyllene, Limonene, Myrcene
- True ‘Hybrid’ varietals
- Tasting Notes – Deserts, Doughs, Citrusy & Spicy
- Effects – Stimulating, Racy, Uplifting, Comforting
- Common Cultivars – Classic Bubba Kush, GSC, Gelatos, Cakes
- Any shift in codominance of Caryophyllene & Limonene
“Exotics” (Rare Terpene Combinations) Class
- True ‘Hybrid’ varietals
- Tasting notes – varied based on chemistry of entry
- Effect – varied based on chemistry of entry
- Common Cultivars – rarest terpene profiles entered into the Emerald Cup Competition
This game-changing development in cannabis classification levels the playing ground for the 2022 Cup as well as market competitiveness amongst brands. The system seeks to become an open-source, globally recognised grading solution for Cannabis, with six simple classes/names/descriptions. In the same way that a Chardonnay would not be tested against a Merlot in the wine business, this new system permits strains with comparable profiles to be judged against each other. This new classification system will also be used at the California State Fair Cannabis Awards in July 2022.
The 2022 Emerald Cup Awards will be presented live on stage on May 14th at the Green Street Festival in Downtown Los Angeles, California.
The Sativa Preservation Society Project Will Protect Rare Haze Genetics
Space Coyote, the totally cosmic cannabis company, has launched the Sativa Preservation Society Project — a movement that protects Haze genetics while paying homage to the custodians and cultivators who kept the seeds alive.
Celebrators of the cannabis culture’s stoner heritage, Space Coyote’s aesthetic and ethos embraces the vibes and psychedelic Seventies scene, where the creativity and community of cannabis intersect.
Co-founder and self-confessed ‘Sativa Diva’ Libby Cooper calls it the “ultimate passion project”.
“We’re truly passionate about saving these genetics that are the actual grandmothers of every modern-day sativa strains that people love — all of these desert strains, all of the fruity strains,” Cooper tells me from the Space Coyote van en route to Hall of Flowers.
Founding the Sativa Preservation Society Project
The concept of the Sativa Preservation Society Project was years in incubation as the Space Coyote team deliberated over how to bring it to life. It was important for them to give back to the community while helping to educate about the history of cannabis culture.
The stars aligned earlier this year when the team met Bam Vachher-Gnanathurai, nursery and plant breeding manager from the Posibl Project in Salina. A mutual love of the unique effects of Haze genetics made for a truly cosmic outcome.
“Bam is super passionate about sativa,” said Cooper. “When we went and met up with Bam for the very first time, he rolled a blunt from Cuban Black. It was such an amazing experience to smoke that flower.”
“The initial conversation of the Sativa Preservation Society coming to life happened during that smoke session. It was like, ‘holy shit, we could actually do this.’”
The Haze Experience
The Sativa Preservation Society Project is launching with three incredibly rare cultivars — Cuban Black Haze, Uptown Haze (also known as A5 Haze), and C5 Haze — all of which were originally cultivated in the 1980s by legendary grower Neville Schoenmaker. The flower will be available as bagged eighths and as infused prerolls.
Cooper likens the Haze experience to being “a bit like mushrooms” — colors are brighter, your smell is enhanced and your hearing is sharper.
“It’s really like a cup of coffee without any jitteriness or anxiety usually associated with sativas. This is pure energy without any sort of adverse effects,” explains Cooper. “You really feel as if your eyelids are getting peeled back — you’re awake, you’re uplifted. Basically, I smoke it and I immediately start stretching.”
“Many sativa genetics are dying out due to a number of reasons,” says Cooper. “Typically, they are more difficult to grow, have a longer curing time, and the fluffy buds are easily crushed in transit.” All of which makes sativas less cost-effective in California’s highly competitive legal market.
“This truly is the first time these original sativa strains are going to be commercially grown,” says Cooper. “It really wouldn’t have been possible, funnily enough, without this group named Posibl.”
Learn more about the Sativa Preservation Society Project in the video above. While you’re at it, find your nearest Space Coyote here.
Peach Oz: This Sweet And Juicy Cultivar Will Stimulate Your Creativity
If you’re looking for a premium cultivar with legendary genetics and a euphoric high, look no further than Peach Oz, the latest addition to Wonderbrett’s stellar strain menu.
A cross of Peach Rings with OZ Kush and a descendent of Zkittlez, the sweet, stimulating citrus taste profile of Peach Oz will get your creative juices flowing.
While the cultivar may be new to the public, according to Wonderbrett Co-Founder and famed Breeder Brett Feldman, it’s five-years-old in the world of genetics.
“There’s only a small handful of heady smokers who follow these things,” says Feldman. “I wanted to bring it to the masses to share the experience with everybody. That’s where my passion comes from with this strain. Similar to an amazing dish at a restaurant, you want to share it with your friends.”
Grown in small-batches at scale from the company’s state-of-the-art Long Beach cultivation facility, the strain was first created by Dying Breed Seeds, then perfected by Cannabis By Corey, before making its way to Feldman.
Bursting with flavors and aromas that bring to mind the sweet ocean breeze and fragrant fruit orchards of the California sunshine state, Peach OZ’s four dominant terpenes: Caryophyllene, Linalool, Limonene and Humulene, create a distinct sweet taste of ripe peaches, citrus candy and cream.
“When any strain has that unique, recognizable consistency in its flavor, whether that be peach, lemon or orange, that’s what myself and other breeders appreciate most and look for when bringing a genetic like this to market. It’s mind-blowing what Peach OZ can do that, translating a fruit flavor to a smoking experience,” explained Feldman.
Peach OZ is available at select dispensary and at Wonderbrett’s flagship dispensary in L.A.